UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): June 19, 2013
ZELTIQ Aesthetics, Inc.
(Exact name of registrant as specified in its charter)
| Delaware | 001-35318 | 27-0119051 | ||
| (State or other jurisdiction of incorporation) |
(Commission File Number) |
(I.R.S. Employer Identification No.) |
4698 Willow Road, Suite 100
Pleasanton, CA 94588
(Address of principal executive offices and zip code)
Registrant’s telephone number, including area code: (925) 474-2500
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| ¨ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
| Item 5.07. | Submission of Matters to a Vote of Security Holders |
ZELTIQ Aesthetics, Inc. held its Annual Meeting of Stockholders on June 19, 2013. The following is a brief description of each matter voted upon at the Annual Meeting, as well as the final tally of the number of votes cast (a) for or withheld for the two directors, and (b) for, against or abstaining for the other matter, as well as the number of broker non-votes with respect to each matter. A more complete description of each matter is set forth in ZELTIQ’s definitive proxy statement filed with the Securities and Exchange Commission on April 30, 2013.
1. ZELTIQ’s stockholders elected the two directors proposed by ZELTIQ for re-election, to serve until ZELTIQ’s 2016 Annual Meeting of Stockholders and until their successors have been elected and qualified. The tabulation of votes on this matter was as follows:
| Nominee |
Shares Voted For |
Shares Withheld |
||||||
| Bryan E. Roberts, Ph.D. |
31,641,011 | 861,600 | ||||||
| Andrew N. Schiff. M.D. |
31,917,406 | 585,205 | ||||||
There were 2,484,847 broker non-votes for this proposal.
2. ZELTIQ’s stockholders ratified the selection of PricewaterhouseCoopers LLP as the independent registered public accounting firm of ZELTIQ for its fiscal year ending December 31, 2013. The tabulation of votes on this matter was as follows:
| Shares voted for: |
34,891,714 | |||
| Shares voted against: |
43,910 | |||
| Shares abstaining: |
51,834 | |||
| Broker non-votes: |
0 |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| ZELTIQ AESTHETICS, INC. | ||||
| Dated: June 19, 2013 | By: | /s/ Sergio Garcia | ||
| Sergio Garcia | ||||
| Senior Vice President, General Counsel and Corporate Secretary | ||||